IA
HIMS icon

IFP Advisors’s Hims & Hers Health HIMS Stock Holding History

IFP Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Sell
783
-629
-45% -$16.9K ﹤0.01% 2773
2026
Q1 		$29.3K Sell
1,412
-2,268
-62% -$53.6K ﹤0.01% 2564
2025
Q4 		$119K Buy
3,680
+1,858
+102% +$79.6K ﹤0.01% 1681
2025
Q3 		$103K Sell
1,822
-286
-14% -$14.7K ﹤0.01% 1657
2025
Q2 		$114K Buy
2,108
+1,279
+154% +$57.8K ﹤0.01% 1557
2025
Q1 		$24.5K Sell
829
-125
-13% -$4.64K ﹤0.01% 2220
2024
Q4 		$23.1K Buy
954
+827
+651% +$20.5K ﹤0.01% 2182
2024
Q3 		$2.34K Hold
127
– – ﹤0.01% 2876
2024
Q2 		$2.56K Hold
127
– – ﹤0.01% 2760
2024
Q1 		$1.97K Hold
127
– – ﹤0.01% 2695
2023
Q4 		$1.13K Hold
127
– – ﹤0.01% 2792
2023
Q3 		$799 Hold
127
– – ﹤0.01% 3043
2023
Q2 		$1.19K Hold
127
– – ﹤0.01% 3035
2023
Q1 		$1.96K Buy
+127
New +$1.11K ﹤0.01% 2902
2021
Q1 		– Sell
-6,274
Closed -$105K – 3093
2020
Q4 		$94K Buy
+6,274
New +$69.7K ﹤0.01% 1164

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IFP Advisors's HIMS Position: Q2 2026 in Review

IFP Advisors reduced its Hims & Hers Health (HIMS) stake by 45% in Q2 2026, selling an estimated $16.9K and leaving 783 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

IFP Advisors first reported a position in HIMS in Q4 2020 and has held it in 15 quarters since. The position peaked at $119K in Q4 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • IFP Advisors held 783 shares of Hims & Hers Health worth $27.1K as of Q2 2026.
  • IFP Advisors sold 629 Hims & Hers Health shares in Q2 2026, an estimated $16.9K.
  • Hims & Hers Health made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2773 holding.
  • IFP Advisors first reported a position in Hims & Hers Health in Q4 2020 and has held it in 15 quarters since.
  • IFP Advisors's Hims & Hers Health position peaked at $119K in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.